Plasma is the raw material for the manufacture of plasma-derived medicinal products, which are life-saving medicines.
Plasma processing is assigned to plasma fractionation companies through public tenders, in compliance with inter-regional agreements.

All steps from the donor to the patient

Plasma is the raw material for the manufacture of plasma-derived medicinal products, which are life-saving medicines. Plasma processing is assigned to plasma fractionation companies through public tenders, in compliance with inter-regional agreements.

All steps from the donor to the patient

The ownership of plasma as raw material collected in the national territory, as well as of the derived medicinal products, is pubblic.

Regions, individually or in associated form, provide plasma to the pharmaceutical Companies through processing contracts that represent an agreement from the production of the medicinal products. The service of plasma processing is attributed from Regions to the pharmaceutical Company through a public tendering procedure.

What do Regions do?

1. Provide the collected plasma from the Blood Establishments to the authorized companies;
2. Distribute the plasma derived medicinal products to the pharmacies operating in hospitals or to the public pharmacies.

Currently Italy is ranked among the leading countries in Europe for the quantity of plasma collected and sent to the industrial processing.